131 Surveillance of Pseudomonas aeruginosa infections at the Prague CF centre  by Kalferstova, L. et al.
S82 7. Microbiology − Diagnosis and epidemiology Posters
131 Surveillance of Pseudomonas aeruginosa infections at the
Prague CF centre
L. Kalferstova1, K. Dedeckova1, M. Antuskova1, A. Nemec2, P. Drˇevı´nek1. 12nd
Faculty of Medicine Charles University, Department of Medical Microbiology,
Prague, Czech Republic; 2National Institute of Public Health, Laboratory of
Bacterial Genetics, Prague, Czech Republic
Pseudomonas aeruginosa (PA) causes chronic respiratory infections in 40−70% of
adult CF patients. The infection can spread between patients as documented by
identiﬁcation of transmissible strains in some CF centres.
The aim of this study was to set up a surveillance program for PA infections in the
Prague CF centre and to map a local epidemiological situation.
In 2004–2012, we collected 865 PA isolates (244 patients, 1−18 samples/patient).
Three methods were compared for their suitability to be used for surveillance at the
(i) intra- and (ii) inter-patient level: random ampliﬁed polymorphic DNA (RAPD),
multilocus sequence typing (MLST) and pulsed ﬁeld gel electrophoresis (PFGE).
We genotyped 350 isolates (196 pts) using RAPD; 225 of them (153 pts) were also
examined by MLST and 64 isolates (42 pts) by PFGE. While all methods provided
concordant results for strain carriage monitoring at the intrapatient level, RAPD
failed to distinguish interpatient isolates whose unrelatedness was apparent from
other two typing methods.
The analysis
i. was performed with RAPD in 90 patients: the replacement of one PA strain
with another was observed in 19 cases (21%). The MLST-based analysis
ii. revealed great heterogeneity between PA isolates (107 STs in 153 patients;
single ST shared by max. 10 patients).
The surveillance protocol composes of MLST for characterization of initial isolates
and RAPD for subsequent isolates. If an RAPD pattern of a new isolate differs from
the previous one, MLST is carried out to conﬁrm strain replacement. An observed
diversity in the PA population is indicative of accurate anti-epidemic measures set
at the CF centre.
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Objectives: The purpose of this study was to standardize and detect IgG antibodies
against P. aeruginosa in sera of patients from a referral Cystic Fibrosis center in
Brazil, using the ELISA technique.
Methods: Sera from 58 patients diagnosed with CF followed at the Hospital of the
University of Campinas were evaluated for IgG antibodies against P. aeruginosa.
Patients were previously classiﬁed taking into account the P. aeruginosa culture
proﬁle of colonization/infection following the criteria of Lee et al. (2003). For the
determination of antibodies we are using the ELISA IgG Pseudomonas CF®, Statens
Serum Institute (Copenhagen, Denmark). The serology results were compared to
the results of microbiological culture, to verify the agreement between them.
Conclusion: Fifty eight patients (age 0.8–26.0; mean 9.3 y), and according to
microbiological culture, 6.9% were chronic patients, 22.4% intermittent, 37.9%
free of infection, 32.7% never colonized by P. aeruginosa. For the ﬁrst sample
analysed positive serology were ﬁnd for all chronic patients, 61.5% of intermittent,
58.3% of free and 29.4% of never colonized. The high number of patients with
positive serology among intermittent may suggest that they are probably infected
with P. aeruginosa, the same occurring for patients classiﬁed by culture as free
of infection. An apparent important lack of concordance was observed for patients
never colonized with P. aeruginosa, where 29.41% (5 patients) had positive serology,
which might be due to cross-reactivity, cutt-off, or even the limitations of culture.
These are preliminary results and should be further analysed with the follow-up of
these patients.
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Objectives: Highly sensitive and speciﬁc methods are needed to timely identify
P. aeruginosa (PA). We tested the Real-Time (RT) PCR assay method to identify
PA growth from respiratory specimens comparing it with microbiological cultures.
Methods: 754 samples from 96 patients categorized in: “chronic infection” (16 pts,
mean age of 17.7 ys), “intermittent infection” (29 pts, mean age of 8 ys), or
“negative” (51 children, mean age of 6 ys) were processed with RT-PCR assays
in addition to conventional microbiological cultures. The DNA samples extracted
were analyzed for PA by a qualitative real-time PCR assay, BioDetect P. aeruginosa
(Biodiversity), according to the manufacturer’s instructions on the 7500 Real-Time
PCR System instrument (Applied Biosystem).
Results: In the intermittent group (191 samples), 18/59 (30.5%) were found to be
positive only using the PCR method. In the negative group (404 samples), 13/39
(33%) specimens were PA positive only with PCR. No false negative PCR results
were detected when conventional cultures were positive, but in total 38 specimens
were PCR positive with a negative culture growth. Positive PCR results (with
negative cultures) were followed by more intensive clinical and microbiological
surveillance. The greater sensitivity of Real-Time PCR to cultures in identifying
also a very low bacterial charge allows an earlier diagnosis, as in 7 “negative”
subjects, RT PCR detected the PA presence before the conventional microbiological
test did.
Conclusion: RT-PCR test was more sensitive in identifying PA than microbiological
cultures. The usefulness of RT-PCR should be also tested in the follow-up of
eradication therapy efﬁcacy.
134 Serology and clinical parameters for diagnosis of Pseudomonas
aeruginosa infection in children with cystic ﬁbrosis
S. Castanhinha1, L. Pereira1, S. Aguiar2, M. Ramirez2, T. Rodrigues3, J. Melo
Cristino2, C. Barreto1. 1Cystic Fibrosis Centre, Hospital Santa Maria, CHLN,
Lisbon, Portugal; 2Microbiology Institute, Faculdade de Medicina de Lisboa,
Lisbon, Portugal; 3Biomathematics Laboratory, Faculdade de Medicina de Lisboa,
Lisbon, Portugal
Pseudomonas aeruginosa (Pa) early pulmonary infection in children with Cystic
Fibrosis (CF) is difﬁcult to diagnose. Serology has been used as a useful tool to
detect it.
Objectives: Determine clinical factors associated with Pa infection in CF children
and their serologic status.
Methods: Cross sectional analysis of clinical parameters (year before serology)
and of antibodies against 3 Pa antigens (alkaline protease; elastase; exotoxin A;
Mediagnost™, Reutling, Germany) in children with CF. Pa infection was determined
based on regular culture (respiratory secretions) on the previous year. Results were
compared with culture (reference standard). Positive serology: 1 antigen positive
determination.
Results: 40 patients were included (10.5 years [1−21], 60% girls). Pa infection was
established: chronic in 8 patients (all were seropositive), intermittent in 17 (88.2%
seronegative); 15 non-infected (all seronegative). Serology had 100% speciﬁcity,
40% sensitivity (kappa = 0.33), 100% positive predictive value (PPV), 50% negative
predictive value (NPV) for Pa infection and accuracy 62.5%. Those with positive
serology (n = 10) had signiﬁcant lower median FEV1 (64%P [32−87] vs 91 [37–
128], p = 0.03) and had a tendency for lower BMI z-score (−0.9 [−2.3−0.3] vs −0.2
[−2.8−1.6], p = 0.06). Treatment duration, genotype and pancreatic function were
similar.
Conclusions: Pa seropositive patients had lower lung function. Serology was
speciﬁc for Pa infection and had high PPV, but sensitivity and NPV were lower than
in previous studies. Serology may be considered as adjuvant to culture but clinical
and serologic follow-up is needed to verify if seroconversion indicates evolution to
Pa chronicity.
